Chemoinformaics analysis of 3,4-Dimethoxystyrene
| Molecular Weight | 164.204 | nRot | 3 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 7 |
| Exact Molecular Weight | 164.084 | nRing | 1 |
| Solubility: LogS | -2.755 | nHRing | 0 |
| Solubility: LogP | 2.459 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 26.3055 |
| nHD | 0 | BPOL | 15.5105 |
| QED | 0.682 |
| Synth | 1.684 |
| Natural Product Likeliness | 0.291 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.029 |
| Pgp-sub | 0.393 |
| HIA | 0.005 |
| CACO-2 | -4.49 |
| MDCK | 0.0000205 |
| BBB | 0.958 |
| PPB | 0.858162 |
| VDSS | 1.284 |
| FU | 0.147152 |
| CYP1A2-inh | 0.958 |
| CYP1A2-sub | 0.926 |
| CYP2c19-inh | 0.178 |
| CYP2c19-sub | 0.891 |
| CYP2c9-inh | 0.061 |
| CYP2c9-sub | 0.841 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.918 |
| CYP3a4-inh | 0.049 |
| CYP3a4-sub | 0.528 |
| CL | 10.249 |
| T12 | 0.829 |
| hERG | 0.056 |
| Ames | 0.038 |
| ROA | 0.053 |
| SkinSen | 0.648 |
| Carcinogencity | 0.547 |
| EI | 0.971 |
| Respiratory | 0.258 |
| NR-Aromatase | 0.108 |
| Antiviral | No |
| Prediction | 0.886862 |